FI963882A0 - Benzotiazolderivat som 5-lipoxigenasbiosyntesinhibitorer - Google Patents

Benzotiazolderivat som 5-lipoxigenasbiosyntesinhibitorer

Info

Publication number
FI963882A0
FI963882A0 FI963882A FI963882A FI963882A0 FI 963882 A0 FI963882 A0 FI 963882A0 FI 963882 A FI963882 A FI 963882A FI 963882 A FI963882 A FI 963882A FI 963882 A0 FI963882 A0 FI 963882A0
Authority
FI
Finland
Prior art keywords
pct
sec
inhibitors
heterocyclic compounds
lipoxygenase
Prior art date
Application number
FI963882A
Other languages
English (en)
Finnish (fi)
Other versions
FI963882A (sv
Inventor
James F Eggler
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI963882A0 publication Critical patent/FI963882A0/sv
Publication of FI963882A publication Critical patent/FI963882A/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI963882A 1994-03-28 1996-09-27 Benzotiazolderivat som 5-lipoxigenasbiosyntesinhibitorer FI963882A (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21878894A 1994-03-28 1994-03-28
PCT/IB1995/000037 WO1995026346A1 (en) 1994-03-28 1995-01-18 Benzisothiazoles derivatives as inhibitors of 5-lipoxygenase biosynthesis

Publications (2)

Publication Number Publication Date
FI963882A0 true FI963882A0 (sv) 1996-09-27
FI963882A FI963882A (sv) 1996-09-27

Family

ID=22816518

Family Applications (1)

Application Number Title Priority Date Filing Date
FI963882A FI963882A (sv) 1994-03-28 1996-09-27 Benzotiazolderivat som 5-lipoxigenasbiosyntesinhibitorer

Country Status (11)

Country Link
US (1) US5665749A (sv)
EP (1) EP0752990B1 (sv)
JP (1) JP2841120B2 (sv)
AT (1) ATE169298T1 (sv)
CA (1) CA2186513C (sv)
DE (1) DE69503890T2 (sv)
DK (1) DK0752990T3 (sv)
ES (1) ES2119377T3 (sv)
FI (1) FI963882A (sv)
GR (1) GR3027598T3 (sv)
WO (1) WO1995026346A1 (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0316546D0 (en) 2003-07-15 2003-08-20 Novartis Ag Process for the manufacture of organic compounds
DE102005005397B4 (de) * 2005-02-05 2008-08-21 Lts Lohmann Therapie-Systeme Ag Isolierung von N-Butylbenzolsulfonamid, Synthese von Benzolsulfonamid-Derivaten sowie Verwendung von N-Butylbenzolsulfonamid und Benzolsulfonamid-Derivaten zur Behandlung der benignen Prostatahyperplasie und/oder des Prostatakarzinoms
NZ624963A (en) 2009-04-29 2016-07-29 Amarin Pharmaceuticals Ie Ltd Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
EP3268085A4 (en) 2015-03-13 2018-10-31 The Board of Trustees of The Leland Stanford Junior University Ltb4 inhibition to prevent and treat human lymphedema
US11724991B1 (en) * 2023-01-06 2023-08-15 King Faisal University Selective 5-LO inhibitors for the treatment of bronchial asthma

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8926981D0 (en) * 1988-12-23 1990-01-17 Ici Plc Heterocyclic derivatives
IE70521B1 (en) * 1989-02-28 1996-12-11 Zeneca Pharma Sa Heterocycles with inhibitory activity of 5-lipoxygenase
US5196419A (en) * 1989-02-28 1993-03-23 Imperial Chemical Industries Plc Heterocyclic cyclic ethers
US5134148A (en) * 1989-02-28 1992-07-28 Imperial Chemical Industries Plc Heterocycles for use as inhibitors of leukotrienes
IE911919A1 (en) * 1990-06-21 1992-01-01 Zeneca Ltd Bicyclic heterocyclic compounds
JPH04128276A (ja) * 1990-09-19 1992-04-28 Pfizer Pharmaceut Co Ltd アミノベンゾサルタム誘導体およびその用途

Also Published As

Publication number Publication date
ATE169298T1 (de) 1998-08-15
WO1995026346A1 (en) 1995-10-05
EP0752990A1 (en) 1997-01-15
CA2186513A1 (en) 1995-10-05
DE69503890T2 (de) 1998-12-10
CA2186513C (en) 1999-03-16
DE69503890D1 (de) 1998-09-10
JPH09507678A (ja) 1997-08-05
ES2119377T3 (es) 1998-10-01
US5665749A (en) 1997-09-09
GR3027598T3 (en) 1998-11-30
EP0752990B1 (en) 1998-08-05
MX9604429A (es) 1997-07-31
JP2841120B2 (ja) 1998-12-24
FI963882A (sv) 1996-09-27
DK0752990T3 (da) 1999-02-08

Similar Documents

Publication Publication Date Title
FI945556A0 (sv) Antiinflammatoriska 3-aryl-2-isoxazolinderivat
BR9408174A (pt) Compostos isoxazolina como agentes antiinflamatórios
SG155909A1 (en) Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors
FI945555A0 (sv) Substituerade oxindoler
TW200610757A (en) New pyridazin-3(2H)-one derivatives
NO20070994L (no) N-hydroksamid derivater og anvendelse derav
YU68601A (sh) Jedinjenja i njihova upotreba za pripremu leka za tretiranje astme, alergije i inflamatornih bolesti
SE9900833D0 (sv) Novel combination
FI963882A0 (sv) Benzotiazolderivat som 5-lipoxigenasbiosyntesinhibitorer
MX9603943A (es) Compuestos de isoxazolina como inhibidores de 5-lipooxigenasa.
ATE482956T1 (de) Octahydropyrroloä2, 3, cüpyridinderivative und pharmazeutische verwendung damit
ECSP003389A (es) Compuestos y procedimientos para el tratamiento de asma, alergia y transtornos inflamatorios